Skip to main content
. 2022 Feb 24;63(2):238–244. doi: 10.4111/icu.20210493

Table 1. Clinical characteristics of the study subjects.

Variable BPH Pca p-value
Patient number 53 63
Age (y) 70.85±8.16 67.27±6.76 0.011*
PSA (ng/mL) 1.87 (0.96–4.97) 11.62 (5.15–17.90) <0.001
Operation
TURP 53 (100.0) 4 (6.3)
Radical prostatectomy 59 (93.7)
Gleason score
7 (3+4) 41 (65.1)
7 (4+3) 16 (25.4)
≥8 6 (9.5)
Stage
T2 29 (46.0)
T3 28 (44.4)
T4 or metastasis 6 (9.5)

Values are presented as mean±standard deviation, median (interquartile range), or number (%).

BPH, benign prostate hyperplasia; PCa, prostate cancer; PSA, prostate-specific antigen; TURP, transurethral resection of the prostate.

p-values were obtained using the *Student’s t-test and the Mann–Whitney U-test.